Myth Spotlight:
It’s the next-gen Botox—it lasts longer, works faster, and is ready-to-use!
Must be better, right?
That’s what Galderma’s marketing machine wants you to believe. The phrase
“PEARL™ Technology” gets thrown around like it’s a Nobel-winning
innovation. And let’s be real—clinics are already prepping their launch parties
for it like it’s injectable Easter Bunny
Reality Check:
Yes, Relfydess is a ready-to-use liquid botulinum toxin, and that’s kinda cool.
Saves time. Removes reconstitution errors. Might help with dose
consistency
But is that actually new or better?
- Complex-free”? So is Bocouture. That’s not news.
- Faster onset? Sure—some patients can see action on Day 1. But so do plenty on Azzalure or Letybo. Real-life variability makes this stat less impressive when you’re dealing with skin, stress, and metabolism.
- 6-month duration? The headline stat. But Letybo and even Botox in realworld use have also shown longevity in that range—if you're dosing correctly and patients aren’t metabolising toxins like hummingbirds on espresso.
Let’s not forget—longer duration could also mean:
- Less frequent patient visits = less income
- More risk of muscle atrophy or frozen faces if you're overdoing it
- More challenging tweaks if someone doesn’t like the result
Truth Bomb:
Relfydess isn’t the second coming. It’s a nice-to-have, not a must-switch.
Use it if:
- You value speed over flexibility.
- You’re marketing to “premium” patients who want to brag about being first.
- You want to simplify operations protocols.
But if your current toxin works, your results are solid, and you don’t need to buy into the latest hype storm.
Stick to what works. Don’t get drunk on the buzzwords.
Hot seat Q: Are you chasing better results or just newer packaging?
HARRY’S HONEST HOUR: “The Time I Got Burned By The ‘Next Big Thing’ Toxin
Confession Corner:
I once dumped my go-to toxin for a flashy new one because some KOL at a conference whispered, “This one’s smoother and patients love it.” You know the type—always jet-setting and name-dropping faster than a Love Island contestant with a fake brand deal.
So, I switched. Guess what?
- Dosing was a guessing game.
- My results were inconsistent AF
- I had a loyal Toxin patient nearly slap me because her crow’s feet were still dancing 10 days later.
Lesson In Wisdom:
“New” doesn’t mean “better.”
It means untested in the real world, not stress-tested across the weird anatomy, fast metabolizers, and unpredictable lifestyle habits of real patients. It means you become the guinea pig. And unless Galderma’s cutting me a cheque to experiment, I’ll pass.
Quick Win:
When a new product lands:
When a new product lands:
- Don’t switch clinic-wide
- Trial on low-risk zones or non-demanding patients
- Get 10+ uses under your belt before you form an opinion
Have you ever regretted chasing the shiny new thing instead of trusting your experience? Reply to this email or DM me—would love to swap war stories.
PS: If you want my full research notes including 132 citations, DM me “NERD” and I’ll ping it across.
